Cargando…
Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion
Deguelin is a nature-derived chemopreventive drug. Endothelial progenitor cells (EPCs) are bone-marrow (BM)-derived key components to induce new blood vessels in early tumorigenesis and metastasis. Here we determined whether deguelin inhibits EPC function in vitro and in vivo at doses not affecting...
Autores principales: | Nguyen, Minh Phuong, Lee, Dongjin, Lee, Se-Hyung, Lee, Hye-Eun, Lee, Ho-Young, Lee, You Mie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599291/ https://www.ncbi.nlm.nih.gov/pubmed/26078334 |
Ejemplares similares
-
Hypoxia-Induced Endothelial Progenitor Cell Function Is Blunted in Angiotensinogen Knockout Mice
por: Choi, Jin-Hwa, et al.
Publicado: (2014) -
Deguelin Suppresses Pancreatic Tumor Growth and Metastasis by Inhibiting Epithelial to Mesenchymal Transition in an Orthotopic Model()
por: Boreddy, Srinivas Reddy, et al.
Publicado: (2012) -
Stereocontrolled semi-syntheses of deguelin and tephrosin
por: Russell, David A., et al.
Publicado: (2017) -
The Biphasic Effects of Oxidized-Low Density Lipoprotein on the Vasculogenic Function of Endothelial Progenitor Cells
por: Lin, Feng-Yen, et al.
Publicado: (2015) -
Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway
por: Li, Ming, et al.
Publicado: (2017)